Effect of Light on Human Circadian Physiology
- PMID: 20161220
- PMCID: PMC2717723
- DOI: 10.1016/j.jsmc.2009.01.004
Effect of Light on Human Circadian Physiology
Abstract
The circadian system in animals and humans, being near but not exactly 24-hours in cycle length, must be reset on a daily basis in order to remain in synchrony with external environmental time. This process of entrainment is achieved in most mammals through regular exposure to light and darkness. In this chapter, we review the results of studies conducted in our laboratory and others over the past 25 years in which the effects of light on the human circadian timing system were investigated. These studies have revealed, how the timing, intensity, duration, and wavelength of light affect the human biological clock. Our most recent studies also demonstrate that there is much yet to learn about the effects of light on the human circadian timing system.
Conflict of interest statement
Dr. Duffy reports no conflicts of interest. Dr. Czeisler has received consulting fees from or served as a paid member of scientific advisory boards for: Actelion, Ltd.; Avera Pharmaceuticals, Inc.; Axon Labs, Inc.; Cephalon, Inc.; Delta Airlines; Eli Lilly and Co.; Fedex Kinko’s; Garda Inspectorate, Republic of Ireland, Fusion Medical Education, LLC, Hypnion, Inc.; Morgan Stanley; Sanofi-Aventis, Inc.; the Portland Train Blazers; Sleep Multimedia, Inc.; Sleep Research Society (for which Dr. Czeisler served as president); Respironics, Inc.; Koninklijke Philips Electronics, N.V.; Sepracor, Inc.; Somnus Therapeutics, Inc.; Takeda Pharmaceuticals; Vanda Pharmaceuticals, Inc., Vital Issues in Medicine and Warburg-Pincus. Dr. Czeisler also owns an equity interest in Axon Labs, Inc.; Lifetrac, Inc.; Somnus Therapeutics, Inc.; and Vanda Pharmaceuticals, Inc.
Dr. Czeisler has received lecture fees from the Accreditation Council of Graduate Medical Education; Alfresa; Cephalon, Inc.; Clinical Excellence Commission (Australia); Dalhousie University; Duke University Medical Center; Institute of Sleep Health Promotion (NPO); London Deanery; Morehouse School of Medicine; Sanofi-Aventis, Inc.; Takeda; Tanabe Seiyaku Co., Ltd.; Tokyo Electric Power Company (TEPCO).
Dr. Czeisler has also received clinical trial research contracts from Cephalon, Inc., Merck & Co., Inc., and Pfizer, Inc.; an investigator-initiated research grant from Cephalon, Inc.; and his research laboratory at the Brigham and Women’s Hospital has received unrestricted research and education funds and/or support for research expenses from Cephalon, Inc., Koninklijke Philips Electronics, N.V., ResMed, and the Brigham and Women’s Hospital.
The Harvard Medical School Division of Sleep Medicine (HMS/DSM), which Dr. Czeisler directs, has received unrestricted research and educational gifts and endowment funds from: Boehringer Ingelheim Pharmaceuticals, Inc., Cephalon, Inc., George H. Kidder, Esq., Gerald McGinnis, GlaxoSmithKline, Herbert Lee, Hypnion, Jazz Pharmaceuticals, Jordan’s Furniture, Merck & Co., Inc., Peter C. Farrell, Ph.D., Pfizer, ResMed, Respironics, Inc., Sanofi-Aventis, Inc., Sealy, Inc., Sepracor, Inc., Simmons, Sleep Health Centers LLC, Spring Aire, Takeda Pharmaceuticals, Tempur-Pedic, Aetna US Healthcare, Alertness Solutions, Inc., Axon Sleep Research Laboratories, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Catalyst Group, Cephalon, Inc., Clarus Ventures, Comfortaire Corporation, Committee for Interns and Residents, Farrell Family Foundation, George H. Kidder, Esq., GlaxoSmithKline, Hypnion, Inc., Innovative Brands Goup, Nature’s Rest, Jordan’s Furniture, King Koil Sleep Products, King Koil, Division of Blue Bell Mattress, Land and Sky, Merck Research Laboratories, MPM Capital, Neurocrine Biosciences, Inc., Orphan Medical/Jazz Pharmaceuticals, Park Place Corporation, Pfizer Global Pharmaceuticals, Pfizer Healthcare Division, Pfizer, Inc., Pfizer/Neurocrine Biosciences, Inc., Purdue Pharma L. P., ResMed, Inc., Respironics, Inc., Sanofi-Aventis, Inc., Sanofi-Synthelabo, Sealy Mattress Company, Sealy, Inc., Sepracor, Inc., Simmons Co., Sleep Health Centers LLC, Spring Air Mattress Co., Takeda Pharmaceuticals, Tempur-Pedic Medical Division, Total Sleep Holdings, Vanda Pharmaceuticals, Inc., and the Zeno Group, together with gifts from many individuals and organizations through an annual benefit dinner.
The HMS/DSM Sleep and Health Education Program has received Educational Grant funding from Cephalon, Inc., Takeda Pharmaceuticals, Sanofi-Aventis, Inc. and Sepracor, Inc.
Dr. Czeisler is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker). Since 1985, Dr. Czeisler has also served as an expert witness on various legal cases related to sleep and/or circadian rhythms.
Figures



Similar articles
-
Synchronization of the mammalian circadian timing system: Light can control peripheral clocks independently of the SCN clock: alternate routes of entrainment optimize the alignment of the body's circadian clock network with external time.Bioessays. 2015 Oct;37(10):1119-28. doi: 10.1002/bies.201500026. Epub 2015 Aug 7. Bioessays. 2015. PMID: 26252253 Free PMC article. Review.
-
Social influences on mammalian circadian rhythms: animal and human studies.Biol Rev Camb Philos Soc. 2004 Aug;79(3):533-56. doi: 10.1017/s1464793103006353. Biol Rev Camb Philos Soc. 2004. PMID: 15366762 Review.
-
Entrainment of the human circadian system by light.J Biol Rhythms. 2005 Aug;20(4):326-38. doi: 10.1177/0748730405277983. J Biol Rhythms. 2005. PMID: 16077152 Review.
-
Artificial light at night shifts daily activity patterns but not the internal clock in the great tit (Parus major).Proc Biol Sci. 2018 Mar 28;285(1875):20172751. doi: 10.1098/rspb.2017.2751. Proc Biol Sci. 2018. PMID: 29593108 Free PMC article.
-
Functional Contributions of Strong and Weak Cellular Oscillators to Synchrony and Light-shifted Phase Dynamics.J Biol Rhythms. 2016 Aug;31(4):337-51. doi: 10.1177/0748730416649550. Epub 2016 May 24. J Biol Rhythms. 2016. PMID: 27221103
Cited by
-
Keeping an eye on circadian time in clinical research and medicine.Clin Transl Med. 2022 Dec;12(12):e1131. doi: 10.1002/ctm2.1131. Clin Transl Med. 2022. PMID: 36567263 Free PMC article. Review.
-
Mathematical modeling of circadian rhythms.Wiley Interdiscip Rev Syst Biol Med. 2019 Mar;11(2):e1439. doi: 10.1002/wsbm.1439. Epub 2018 Oct 17. Wiley Interdiscip Rev Syst Biol Med. 2019. PMID: 30328684 Free PMC article. Review.
-
Long-Term Nightshift Work and Breast Cancer Risk: An Updated Systematic Review and Meta-Analysis with Special Attention to Menopausal Status and to Recent Nightshift Work.Cancers (Basel). 2021 Nov 26;13(23):5952. doi: 10.3390/cancers13235952. Cancers (Basel). 2021. PMID: 34885062 Free PMC article. Review.
-
Associations Between Timing of Meals, Physical Activity, Light Exposure, and Sleep With Body Mass Index in Free-Living Adults.J Phys Act Health. 2019 Mar 1;16(3):214-221. doi: 10.1123/jpah.2017-0389. Epub 2019 Feb 24. J Phys Act Health. 2019. PMID: 30798690 Free PMC article.
-
Efficacy and tolerability of agomelatine in the treatment of depression.Patient Prefer Adherence. 2014 May 2;8:603-12. doi: 10.2147/PPA.S42789. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 24833894 Free PMC article. Review.
References
-
- Moore RY, Lenn NJ. A retinohypothalamic projection in the rat. J Comp Neurol. 1972;146:1–14. - PubMed
-
- Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science. 1990;247:975–978. - PubMed
-
- Klein DC, Moore RY, Reppert SM, editors. Suprachiasmatic nucleus: the mind's clock. New York: Oxford University Press; 1991.
-
- Weaver DR. The suprachiasmatic nucleus: a 25-year retrospective. J Biol Rhythms. 1998;13(2):100–112. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous